RESUMO
INTRODUCTION AND OBJECTIVES: Nasotracheal intubation was advocated to increase patients comfort and tube tolerance, but no study showed a clear benefit of nasotracheal intubation over orotracheal intubation. Neurocritically ill patients are a fragile group with specific requirements regarding ventilation and sedation. The aim of this study was to evaluate whether nasotracheal intubation might reduce length of mechanical ventilation in neurocritically ill patients. MATERIALS AND METHODS: We conducted a retrospective cohort study with propensity matched analysis including all patients who underwent prolonged mechanical ventilation in the neurocritical Intensive Care Unit. RESULTS: A total of 4030 patients were admitted during the period of interest and 312 entered the final analysis. Propensity score analysis identified 74 matched couples. Length of mechanical ventilation in patients who underwent early nasotracheal intubation resulted to be statistically significantly shorter than patients who underwent orotracheal intubation. Accordingly, length of sedation was significantly lower in patients with nasotracheal intubation, while no difference in complications occurred with similar length of stay. CONCLUSIONS: In critical care units using nasotracheal intubation in the standard management of patients, the nasotracheal route was associated with lesser need for sedatives leading to shorter mechanical ventilation in neurocritical patients. However, causality has to be proven by future randomized controlled trials.
Assuntos
Hipnóticos e Sedativos , Respiração Artificial , Humanos , Pontuação de Propensão , Estudos Retrospectivos , Tempo de InternaçãoRESUMO
Introducción y objetivos: Se ha aducido que la intubación nasotraqueal incrementa la comodidad y la tolerancia al tubo por parte del paciente, aunque ningún estudio ha demostrado un beneficio claro de la intubación nasotraqueal con respecto a la intubación orotraqueal. Los pacientes neurocríticos constituyen un grupo frágil con necesidades específicas, en cuanto a ventilación y sedación. El objetivo de este estudio fue evaluar si la intubación nasotraqueal podría reducir la duración de la ventilación mecánica en los pacientes neurocríticos. Materiales y métodos: Realizamos un estudio prospectivo de cohorte con análisis pareado de propensión, incluyendo a todos los pacientes que recibieron ventilación mecánica en la Unidad de Cuidados Intensivos neurocríticos. Resultados: Se ingresó a un total de 4.030 pacientes durante el periodo de interés, incluyendo a 312 de ellos en el análisis final. El análisis de la puntuación de propensión identificó a 74 parejas pareadas. La duración de la ventilación mecánica de los pacientes que recibieron intubación nasotraqueal temprana resultó ser significativamente inferior a la de los pacientes que recibieron intubación orotraqueal. Por tanto, la duración de la sedación fue considerablemente inferior en los pacientes con intubación nasotraqueal y no existió diferencia en cuanto a las complicaciones que se producen con las estancias de duración similar. Conclusiones: En las unidades de cuidados críticos que utiliza intubación nasotraqueal en el manejo estándar de los pacientes, la vía nasotraqueal estuvo asociada a una menor necesidad de sedantes, lo cual conllevó una ventilación mecánica más breve en los pacientes neurocríticos. Sin embargo, los ensayos controlados aleatorizados deberán probar la causalidad.(AU)
Introduction and objectives: Nasotracheal intubation was advocated to increase patients comfort and tube tolerance, but no study showed a clear benefit of nasotracheal intubation over orotracheal intubation. Neurocritically ill patients are a fragile group with specific requirements regarding ventilation and sedation. The aim of this study was to evaluate whether nasotracheal intubation might reduce length of mechanical ventilation in neurocritically ill patients. Materials and methods: We conducted a retrospective cohort study with propensity matched analysis including all patients who underwent prolonged mechanical ventilation in the neurocritical Intensive Care Unit. Results: A total of 4030 patients were admitted during the period of interest and 312 entered the final analysis. Propensity score analysis identified 74 matched couples. Length of mechanical ventilation in patients who underwent early nasotracheal intubation resulted to be statistically significantly shorter than patients who underwent orotracheal intubation. Accordingly, length of sedation was significantly lower in patients with nasotracheal intubation, while no difference in complications occurred with similar length of stay. Conclusions: In critical care units using nasotracheal intubation in the standard management of patients, the nasotracheal route was associated with lesser need for sedatives leading to shorter mechanical ventilation in neurocritical patients. However, causality has to be proven by future randomized controlled trials.(AU)
Assuntos
Humanos , Masculino , Respiração Artificial , Intubação Intratraqueal , Unidades de Terapia Intensiva , Pontuação de Propensão , Estudos Prospectivos , Estudos de CoortesRESUMO
OBJECTIVE: Frailty is a relatively new concept for intensivists, and is defined as a status of increased vulnerability to stressors associated with reduced reserve and function of different physiological systems. Supporting the hypothesis that frailty may be an important predictor of poor prognosis among older patients admitted to Intensive Care Unit (ICU), this study seeks to evaluate the association between frailty at ICU admission and short and long-term mortality. DESIGN: An unmatched case-control study was carried out. SETTING: Intensive Care Unit. PATIENTS OR PARTICIPANTS: Patients≥80 years of age admitted to the ICU for medical reasons. INTERVENTIONS: None. MAIN VARIABLES OF INTEREST: The primary outcome was 30-day mortality, while secondary outcomes were ICU mortality and mortality at one year. RESULTS: Most of the patients were classified as frail at ICU admission (55.3%). The prevalence of frailty was higher among those who died than in those who were alive within 30 days from ICU admission (62.3% vs 48.3%, p=0.01). One-year mortality was higher in frail (84.4%) than in non-frail patients (65.2%, p<0.001). In the logistic regression analysis, after adjusting for potential confounders such as chronic diseases, clinical complexity, cause of ICU admission and use of advanced procedures, frailty was seen to be significantly associated to one-year mortality, but not with ICU mortality or 30-day mortality. DISCUSSION: The admission of geriatric patients to the ICU is increasing. Frailty assessment may play an important role in the clinical evaluation of such individuals for triage, but should not be considered a priori as an exclusion criterion for admission.
Assuntos
Fragilidade , Idoso , Estudos de Casos e Controles , Idoso Fragilizado , Humanos , Unidades de Terapia Intensiva , Tempo de InternaçãoRESUMO
Objective: Frailty is a relatively new concept for intensivists, and is defined as a status of increased vulnerability to stressors associated with reduced reserve and function of different physiological systems. Supporting the hypothesis that frailty may be an important predictor of poor prognosis among older patients admitted to Intensive Care Unit (ICU), this study seeks to evaluate the association between frailty at ICU admission and short and long-term mortality.DesignAn unmatched case-control study was carried out.SettingIntensive Care Unit.Patients or participantsPatients≥80 years of age admitted to the ICU for medical reasons.InterventionsNone.Main variables of interestThe primary outcome was 30-day mortality, while secondary outcomes were ICU mortality and mortality at one year.ResultsMost of the patients were classified as frail at ICU admission (55.3%). The prevalence of frailty was higher among those who died than in those who were alive within 30 days from ICU admission (62.3% vs 48.3%, p=0.01). One-year mortality was higher in frail (84.4%) than in non-frail patients (65.2%, p<0.001). In the logistic regression analysis, after adjusting for potential confounders such as chronic diseases, clinical complexity, cause of ICU admission and use of advanced procedures, frailty was seen to be significantly associated to one-year mortality, but not with ICU mortality or 30-day mortality.DiscussionThe admission of geriatric patients to the ICU is increasing. Frailty assessment may play an important role in the clinical evaluation of such individuals for triage, but should not be considered a priori as an exclusion criterion for admission (AU)
Objetivo: «Fragilidad» es un concepto relativamente nuevo para los intensivistas, y se define como un estado de mayor vulnerabilidad frente a los estresores asociados con una reducción de las reservas y del funcionamiento de distintos sistemas fisiológicos. Basándose en la hipótesis de que la fragilidad podría ser un importante factor predictivo de un mal pronóstico en pacientes ancianos ingresados en la unidad de cuidados intensivos (UCI), este estudio tenía por objeto evaluar la asociación entre la fragilidad en el momento del ingreso en la UCI y la mortalidad a corto y largo plazo.DiseñoEstudio de casos y controles sin emparejamiento.ÁmbitoUnidad de cuidados intensivos.Pacientes o participantesPacientes ≥80 años ingresados en la UCI por motivos médicos.IntervencionesNinguna.Variables de interés principalesLa variable principal fue la mortalidad a 30 días, mientras que las variables secundarias fueron la mortalidad en la UCI y al cabo de un año.ResultadosLa mayoría de los pacientes se clasificaron como frágiles en el momento de su ingreso en la UCI (55,3%). La prevalencia de la fragilidad fue más alta entre quienes fallecieron... (AU)
Assuntos
Humanos , Masculino , Feminino , Idoso de 80 Anos ou mais , Unidades de Terapia Intensiva/estatística & dados numéricos , Idoso Fragilizado , Mortalidade Hospitalar , Fragilidade , Tempo de Internação , Estudos de Casos e ControlesRESUMO
OBJECTIVE: Frailty is a relatively new concept for intensivists, and is defined as a status of increased vulnerability to stressors associated with reduced reserve and function of different physiological systems. Supporting the hypothesis that frailty may be an important predictor of poor prognosis among older patients admitted to Intensive Care Unit (ICU), this study seeks to evaluate the association between frailty at ICU admission and short and long-term mortality. DESIGN: An unmatched case-control study was carried out. SETTING: Intensive Care Unit. PATIENTS OR PARTICIPANTS: Patients≥80 years of age admitted to the ICU for medical reasons. INTERVENTIONS: None. MAIN VARIABLES OF INTEREST: The primary outcome was 30-day mortality, while secondary outcomes were ICU mortality and mortality at one year. RESULTS: Most of the patients were classified as frail at ICU admission (55.3%). The prevalence of frailty was higher among those who died than in those who were alive within 30 days from ICU admission (62.3% vs 48.3%, p=0.01). One-year mortality was higher in frail (84.4%) than in non-frail patients (65.2%, p<0.001). In the logistic regression analysis, after adjusting for potential confounders such as chronic diseases, clinical complexity, cause of ICU admission and use of advanced procedures, frailty was seen to be significantly associated to one-year mortality, but not with ICU mortality or 30-day mortality. DISCUSSION: The admission of geriatric patients to the ICU is increasing. Frailty assessment may play an important role in the clinical evaluation of such individuals for triage, but should not be considered a priori as an exclusion criterion for admission.
RESUMO
Healthcare workers involved in aerosol-generating procedures, such as tracheal intubation, may be at elevated risk of acquiring COVID-19. However, the magnitude of this risk is unknown. We conducted a prospective international multicentre cohort study recruiting healthcare workers participating in tracheal intubation of patients with suspected or confirmed COVID-19. Information on tracheal intubation episodes, personal protective equipment use and subsequent provider health status was collected via self-reporting. The primary endpoint was the incidence of laboratory-confirmed COVID-19 diagnosis or new symptoms requiring self-isolation or hospitalisation after a tracheal intubation episode. Cox regression analysis examined associations between the primary endpoint and healthcare worker characteristics, procedure-related factors and personal protective equipment use. Between 23 March and 2 June 2020, 1718 healthcare workers from 503 hospitals in 17 countries reported 5148 tracheal intubation episodes. The overall incidence of the primary endpoint was 10.7% over a median (IQR [range]) follow-up of 32 (18-48 [0-116]) days. The cumulative incidence within 7, 14 and 21 days of the first tracheal intubation episode was 3.6%, 6.1% and 8.5%, respectively. The risk of the primary endpoint varied by country and was higher in women, but was not associated with other factors. Around 1 in 10 healthcare workers involved in tracheal intubation of patients with suspected or confirmed COVID-19 subsequently reported a COVID-19 outcome. This has human resource implications for institutional capacity to deliver essential healthcare services, and wider societal implications for COVID-19 transmission.
Assuntos
Betacoronavirus , Infecções por Coronavirus/transmissão , Pessoal de Saúde , Intubação Intratraqueal , Exposição Ocupacional/efeitos adversos , Pneumonia Viral/transmissão , Adulto , COVID-19 , Infecções por Coronavirus/epidemiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pandemias , Pneumonia Viral/epidemiologia , Modelos de Riscos Proporcionais , Estudos Prospectivos , Risco , SARS-CoV-2RESUMO
No disponible
Assuntos
Humanos , Anestesia/métodos , Anestesia , Complicações Pós-Operatórias/tratamento farmacológico , Sobrevivência , Período Perioperatório/economia , Período Perioperatório/métodos , Período Perioperatório , Respiração Artificial/economia , Comorbidade , Insuficiência Respiratória/tratamento farmacológico , Edema Pulmonar/tratamento farmacológicoRESUMO
BACKGROUND: Inotropes and vasopressors are frequently administered to critically ill patients in order to improve haemodynamic function and restore adequate organ perfusion. However, some studies have suggested a possible association between inotrope administration and increased mortality. We therefore performed a meta-analysis of randomized trials published in the last 20 yr to investigate the effect of these drugs on mortality. METHODS: BioMedCentral, PubMed, Embase and the Cochrane Central Register were searched (all updated April 8th, 2015). Inclusion criteria were: random allocation to treatment, at least one group receiving an inotropic or vasopressor drug compared with at least one group receiving a non-inotropic/vasopressor treatment, study published after 1st January 1994, and systemic drug administration. Exclusion criteria were overlapping populations, studies published as abstract only, crossover studies, paediatric studies and lack of data on mortality. RESULTS: A total of 28 280 patients from 177 trials were included. Overall, pooled estimates showed no difference in mortality between the group receiving inotropes/vasopressors and the control group [4255/14 036 (31.7%) vs. 4277/14 244 (31.8%), risk ratio=0.98 (0.96-1.01), P for effect=0.23, P for heterogeneity=0.30, I2=6%]. A reduction in mortality was associated with inotrope/vasopressor therapy use in settings of vasoplegic syndromes, sepsis and cardiac surgery. Levosimendan was the only drug associated with improvement in survival. Subgroup analysis did not identify any groups with increased mortality associated with inotrope/vasopressor therapy. CONCLUSIONS: Our systematic review found that inotrope/vasopressor therapy is not associated with differences in mortality in the overall population and in the majority of subsettings.
Assuntos
Cardiotônicos/uso terapêutico , Estado Terminal/terapia , Vasoconstritores/uso terapêutico , Cardiotônicos/efeitos adversos , Estado Terminal/mortalidade , Insuficiência Cardíaca/tratamento farmacológico , Insuficiência Cardíaca/mortalidade , Humanos , Ensaios Clínicos Controlados Aleatórios como Assunto , Vasoconstritores/efeitos adversosRESUMO
BACKGROUND: Inodilators are commonly used in critically ill patients, but their effect on survival has not been properly studied to date. The objective of this work was to conduct a network meta-analysis on the effects of inodilators on survival in adult cardiac surgery patients, and to compare and rank drugs that have not been adequately compared in head-to-head trials. METHODS: Relevant studies were independently searched in BioMedCentral, MEDLINE/PubMed, Embase, and the Cochrane Central Register of clinical trials (updated on May 1, 2014). The criteria for inclusion were: random allocation to treatment with at least one group receiving dobutamine, enoximone, levosimendan, or milrinone and at least another group receiving the above inodilators or placebo, performed in cardiac surgical patients. The endpoint was to identify differences in mortality at longest follow-up available. RESULTS: The 46 included trials were published between 1995 and 2014 and randomised 2647 patients. The Bayesian network meta-analysis found that only the use of levosimendan was associated with a decrease in mortality when compared with placebo (posterior mean of OR=0.48, 95% CrI 0.28 to 0.80). The posterior distribution of the probability for each inodilator to be the best and the worst drug showed that levosimendan is the best agent to improve survival after cardiac surgery. The sensitivity analyses performed did not produce different interpretative result. CONCLUSION: Levosimendan seems to be the most efficacious inodilator to improve survival in cardiac surgery.
Assuntos
Procedimentos Cirúrgicos Cardíacos/mortalidade , Vasodilatadores/farmacologia , Teorema de Bayes , Estado Terminal/mortalidade , Dobutamina/farmacologia , Enoximona/farmacologia , Humanos , Hidrazonas/farmacologia , Milrinona/farmacologia , Piridazinas/farmacologia , SimendanaRESUMO
BACKGROUND: One of the most commonly used hypnotics is propofol. Several studies performed in cardiac surgery suggested an increased mortality in patients receiving a propofol-based total intravenous anaesthesia. Furthermore, the possibility of infections and the 'propofol syndrome' have suggested that propofol might be dangerous. Nonetheless, propofol is widely used in different settings because of its characteristics: fast induction, rapid elimination, short duration of action, smooth recovery from anaesthesia, few adverse effects, no teratogenic effects, characteristics that have undoubtedly contributed to its popularity. The effect of propofol on survival is unknown. We decided to carry out a meta-analysis of all randomized controlled studies ever performed on propofol vs. any comparator in any clinical setting. METHODS: Pertinent studies were independently searched in BioMedCentral, PubMed, Embase, Clinicaltrial.gov, and Cochrane Central Register of Clinical Trials by expert investigators. The following inclusion criteria were used: random allocation to treatment, comparison between propofol and any comparator in any clinical setting. RESULTS: One hundred thirty-three studies randomizing 14,516 patients were included. No differences in mortality between patients receiving propofol [349/6957 (5.0%)] vs. any comparator [340/7559 (4.5%)] were observed in the overall population [risk ratio = 1.05, 95% confidence interval (0.93 to 1.18), P = 0.5] and in several sub-analyses. CONCLUSION: Inspite of theoretical concerns, propofol has no detrimental effect on survival according to the largest meta-analysis of randomized trials ever performed on hypnotic drug.
Assuntos
Anestesia Intravenosa , Propofol/farmacologia , Procedimentos Cirúrgicos Cardíacos/mortalidade , Humanos , Propofol/efeitos adversos , Ensaios Clínicos Controlados Aleatórios como AssuntoRESUMO
BACKGROUND: Single dilator technique (SDT) and guide wire dilating forceps (GWDF) are the two most commonly used techniques of percutaneous dilatational tracheostomy (PDT) in critically ill adult patients. We performed a meta-analysis of randomised, controlled trials comparing intraoperative, mid-term and late complications of these two techniques. METHODS: Pertinent studies were searched in BioMedCentral, PubMed, Embase and the Cochrane Central Register of clinical trials. We selected all randomised studies comparing SDT and GWDF techniques in adult critically ill patients published in a peer-reviewed journal. RESULTS: Among 1040 retrieved studies, five eligible studies randomising 363 patients (181 to GWDF, 182 to SDT) were identified. The incidence of the composite outcome difficult cannula insertion/difficult dilation or failure was higher with the GWDF technique (15.5% vs. 4.9 %, P = 0.02). Moreover, intraprocedural bleeding was more common in the GWDF group (19.3% vs. 7.6% in SDT group, P = 0.018). A trend towards an increased incidence of fracture of tracheal rings was noted in the SDT group (6.5% vs. 0.5% in the GWDF group, P = 0.13). No difference in mid-term or long-term complications was observed. CONCLUSION: GWDF technique is associated with a higher incidence of intraprocedural bleeding and of technical difficulties in completing the procedure (difficult cannula insertions/difficult dilations or failures) compared with the SDT technique. No differences were identified in mid-term and long-term complications. Further studies comparing SDT and GWDF in the general population and in subgroups of high-risk patients (like obese or hypoxaemic patients) are warranted.
Assuntos
Instrumentos Cirúrgicos , Traqueostomia/métodos , Adulto , Perda Sanguínea Cirúrgica , Estado Terminal , Interpretação Estatística de Dados , Humanos , Período Intraoperatório , Viés de Publicação , Ensaios Clínicos Controlados Aleatórios como Assunto , Reprodutibilidade dos Testes , Traqueostomia/efeitos adversos , Traqueostomia/instrumentaçãoRESUMO
Mild to severe respiratory dysfunction is still a common issue after cardiac surgery. Postoperative respiratory complications are associated with prolonged hospitalization and worse survival. In this high-risk surgery, non-invasive ventilation could have relevant positive effects. The present narrative concise review aims to summarize available data on the role of non-invasive ventilation before and after cardiac surgery. Non-invasive ventilation exerts its main effects on the pulmonary and on the cardiovascular systems. Non-invasive ventilation can be applied to prevent acute respiratory failure; it can also be prescribed as a curative tool to treat an established postoperative acute respiratory failure. Non-invasive ventilation could also be applied to wean patients from mechanical ventilation. When applied as a preventive tool, the main scope is the prevention of pneumonia by resolving or preventing atelectasis. So far, limited (but encouraging) data are available: its routine use in all patients to prevent postoperative acute respiratory failure cannot be recommended. Non-invasive ventilation to treat postoperative acute respiratory failure has been evaluated more extensively. A failure rate from 10 to 55% was reported. Safety appears preserved, with no relevant hemodynamic complication reported. Non-invasive ventilation has also been applied during percutaneous aortic valve implant in patients unable to lie supine due to severe respiratory limitation and orthopnea. In conclusion, non-invasive ventilation has the potential to be very useful before and after cardiac surgery. So far, results are promising but available data are limited. Training and experience are essential to obtain positive results and to avoid complications.
RESUMO
BACKGROUND: Many studies have compared desflurane, isoflurane, sevoflurane, total i.v. anaesthesia (TIVA), or all in cardiac surgery to assess their effects on patient survival. METHODS: We performed standard pairwise and Bayesian network meta-analyses; the latter allows indirect assessments if any of the anaesthetic agents were not compared in head-to-head trials. Pertinent studies were identified using BioMedCentral, MEDLINE/PubMed, Embase, and the Cochrane Library (last updated in June 2012). RESULTS: We identified 38 randomized trials with survival data published between 1991 and 2012, with most studies (63%) done in coronary artery bypass grafting (CABG) patients with standard cardiopulmonary bypass. Standard meta-analysis showed that the use of a volatile agent was associated with a reduction in mortality when compared with TIVA at the longest follow-up available [25/1994 (1.3%) in the volatile group vs 43/1648 (2.6%) in the TIVA arm, odds ratio (OR)=0.51, 95% confidence interval (CI) 0.33-0.81, P-value for effect=0.004, number needed to treat 74, I(2)=0%] with results confirmed in trials with low risk of bias, in large trials, and when including only CABG studies. Bayesian network meta-analysis showed that sevoflurane (OR=0.31, 95% credible interval 0.14-0.64) and desflurane (OR=0.43, 95% credible interval 0.21-0.82) were individually associated with a reduction in mortality when compared with TIVA. CONCLUSIONS: Anaesthesia with volatile agents appears to reduce mortality after cardiac surgery when compared with TIVA, especially when sevoflurane or desflurane is used. A large, multicentre trial is warranted to confirm that long-term survival is significantly affected by the choice of anaesthetic.
Assuntos
Anestésicos Inalatórios , Anestésicos Intravenosos , Procedimentos Cirúrgicos Cardíacos/métodos , Anestesia Geral/métodos , Anestesia Geral/mortalidade , Teorema de Bayes , Procedimentos Cirúrgicos Cardíacos/mortalidade , Desflurano , Humanos , Isoflurano/análogos & derivados , Éteres Metílicos , Ensaios Clínicos Controlados Aleatórios como Assunto , Sevoflurano , Análise de SobrevidaRESUMO
Se presenta el caso de un recien nacido con el diagnostico inicial de ictericia obstructiva. Los estudios clinicos y bioquimicos practicados para detectar enfermedades infecciosas o geneticometabolicas fueron negativos. La colangiografia transparietohepatica realizada con la aguja de Chiba demostro la indemnidad y permeabilidad de la via biliar intra y extrahepatica. Aunque la practica de este procedimiento es muy dificil en un recien nacido, se concluye que es un metodo alternativo de estudio en pacientes con sospecha de padecer una atresia de la via biliar extrahepatica previo a una mas agresiva laparotomia
Assuntos
Colangiografia , Icterícia NeonatalRESUMO
Se presenta el caso de un recien nacido con el diagnostico inicial de ictericia obstructiva. Los estudios clinicos y bioquimicos practicados para detectar enfermedades infecciosas o geneticometabolicas fueron negativos. La colangiografia transparietohepatica realizada con la aguja de Chiba demostro la indemnidad y permeabilidad de la via biliar intra y extrahepatica. Aunque la practica de este procedimiento es muy dificil en un recien nacido, se concluye que es un metodo alternativo de estudio en pacientes con sospecha de padecer una atresia de la via biliar extrahepatica previo a una mas agresiva laparotomia